Minding the London Stock Exchange’s Business
Independent and Fearless Financial Journalism Funded by Readers
Even a few of our detractors have now come around
FastForward Innovations – now Seed Innovations (SEED) – was a recommendation last year on the N50 website which also features writers here Tom Winnifrith and Steve Moore. That was at a 6.2p offer price, noting the discount to NAV looked severe and looking for operational progress and increased interest particularly in the health area to propel NAV forward again. Little more than two months later the shares had already reached 12p to sell despite the company then stating “it is naturally a more challenging market for fundraising, which could delay the roll-out of future growth plans”. We banked gains, but there has been operational progress, though the shares are currently available at an 8.4p offer price.
And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Ed McDermott of FastForward Innovations (FFWD) on cannabis stocks and his company. This is, I think, the most interesting CEO interview to date. Then I discuss a new share I have invested a five figure sum into on behalf of the company. Finally there is bear raider turned bull, the bard of the Boleyn, Lucian Miers. You can access the show HERE
FastForward Innovations (FFWD) has announced results for its year ended 31st March 2020 including “a large portion of our investments have continued to make positive advances and reach significant milestones in their development”, though also “some challenges”… and this share tip from us is almost 100% ahead on an offer to bid basis after just two months!
In today's podcast I look at the British Journalism Awards and Neil Woodford ( no shocks here folks), Union Jack Oil (UJO) and that planned placing, Tissue Regenix (TRX) as the FD walks, FastForward Innovations (FFWD), and at Plutus Powergen (PPG) , dire news and surely looming insolvency and yet more evidence of not gviving a flying wotsit about stockmarket rules.
Tom covered much of the nonsense surrounding the FastForward Innovations’ (FFWD) placing last week (HERE) but I wanted to look at how Jim Mellon and Lorne Abony got themselves into that particular mess as they seem to have taken a couple of plays straight out of “star fund manager” Neil Woodford’s book.
I start with the announcement late last night from FastFoward Innovations (FFWD) the overvalued investment company run by my good friend the offshore based asset stripper Mr Jim Mellon. I move on to the FRC dealing with Russell McBurnie the disgraced ex FD of RSM Tenon and discuss book cookers, fraudsters. Sam Antar theories and crime and punishment generally. I look at Akers Biosciences (AKR) where book cooking ahead of a placing is alleged, at Zenith (ZEN) and at LPA (LPA) where i would not bottom fish after today's warning for a variety of reasons. Then I note MySquar (FRAUD) is down to 1.15p and I ask John Meyer of SP Angel once more if he will act or is he happy to wash his hands and turn a blind eye to crime. Tonight is a 6 mile training walk and Joshua and I will do two miles this morning. With Gift aid my charity walk on July 28 has now raised almost £10,000. I explain exactly what that means to Woodlarks. If you have not donated, please chip in now with a tenner to get us over £10,000 HERE
If anyone thought anything else other that FastForward Innovations was merely the personal investment vehicle for Jim Mellon and Lorne Abony to dip into at will, today’s massive related party deal with Mellon’s Juvenescence Limited puts it beyond any doubt.
Madness is afoot at FastForward Innovations (FFWD) with the excitement about the impending listing of its cannabis play, Nuuvera, driving the share price up as high as 30p yesterday. This makes no rational sense as I will endeavour to explain but the summary is simple – if you like Nuuvera, buy it in the market for its market value rather than at 4-5 times its value!
The one thing I hate more than being wrong about a share recommendation is being spoofed and falling for it, which is what I think has happened with FastForward Innovations (FFWD). Can’t believe I fell for it but I’m done now – SELL.
I’ve been hugely critical of FastForward Innovations (FFWD) in the past, in the main due to the lack of transparency and the poor performance of Schoold and Vemo, Lorne Abony’s own investments in FastForward’s portfolio; however, today’s news is much more promising and I actually wonder whether it’s worth a dabble!
Tom covered the news of the failed Schoold / Lingo Media merger that FastForward Innovations (FFWD) announced on Friday in his Bearcast (HERE); however, I thought it was worth taking a closer look at the numbers and pondering when the next major write down to FastForward’s portfolio, and Lorne Abony’s reputation, will come.
Investors in various Jim Mellon connected companies such as FastForward Innovations (FFWD) and Port Erin Biopharma (PEBI) may be interested in this analysis of Diabetic Boot Company’s latest six-month accounts to 31 December 2016. The bad news is that it is still losing a fortune although the good news is that at least Mr Mellon is now largely funding it himself.
I’ve been pretty critical of Jim Mellon's FastForward Innovations (FFWD) and its CEO, Lorne Abony, in the past but today’s news is a positive step for one of its investee companies, Nuuvera, and worthy of comment and the only negative relates to the obvious blunder that offends my OCD proof-reading nature.
After months of promises and delays, Jim Mellon's FastForward Innovations (FFWD) finally provided further details of the potential merger of investee company Schoold with Lingo Media this morning. I can see why it was reticent about making the announcement as it doesn’t make pretty reading.
Tom covered the key headlines on the year-end results of Jim Mellon's FastForward Innovations (FFWD) on Friday but I wanted to focus in on a couple of points, most notably the exorbitant amount Lorne Abony, CEO, gets paid considering the despicable way in which he treats his shareholders and the shocking performance, and non-disclosure, of one of the investments that he brought to the table, namely Vemo.
To end my trilogy of tenuously connected pieces, I’m taking a look at four ongoing coma-inducing delays at each of FastForward Innovations (FFWD), i3 Energy and, of course, Aidan Earley’s Newco and wonder which, if any, will win this slow and laborious race.
I’ve written a few times on the travails of The Diabetic Boot Company over time, usually after yet another Jim Mellon-related company lends or invests money in this biotech pipedream. Well, its results have finally come out, two months late, and they make interesting reading.
There’s a few short-term challenges ahead for Jim Mellon's FastForward Innovations (FFWD) but for this piece I wanted to focus on the one I find most amusing, namely its most recent investment in the marijuana space, Nuuvera Corp, which reminds me of an episode of Dennis Waterman’s finest work – New Tricks.
I wrote about the rather unexciting merger between Schoold and Lingo Media that FastForward Innovations (FFWD) announced in March (HERE) but with Lingo Media recently issuing its full year results, I felt it merited an update. They don’t make great reading and I’m beginning to wonder whether the deal will actually go ahead.
I wrote six months ago about the laughable potential RTO deal between Jim Mellon-connected Life Science Developments (LIFE) and Jim’s favourite private investment, The Diabetic Boot Company. Well, surprise, surprise, the deal hasn’t happened and Life Science will be booted off AIM. It’s worth taking a closer look at what has gone on at this farce in the last 18 months.
When reading this morning’s RNS from FastForward Innovation (FFWD), I just had this image of Lorne Abony and Jim Mellon scrabbling around behind the back of the sofas in FastForward Towers looking for some spare change as the cash crunch (detailed HERE) becomes ever more pressing. The announcement related to a change in the lock-in arrangements relating to the sale of the SatoshiPay investment to Blue Star Capital (BLU).
With the exciting news that Falcon Acquisitions (FAL), or Falcon Media House as it is now known, has finally come back to the market after an eight-month suspension, I thought I’d do a review of a few of the interesting bits coming out of the long-awaited prospectus as a counter-balance to the tsunami of bullish noise from all the usual places yesterday. Unsurprisingly, there is staggering lack of disclosure that is all too normal with Standard List companies.
Having been put in a bad mood with the disappointing Schoold deal that I covered HERE, I thought I’d dig a bit deeper to see how much cash is left in Jim Mellon backed FastForward (FFWD) business and what I think that means for the future and why it looks overvalued to me.
I’ve been on the edge of my seat for a number of days as was expecting news from Jim Mellon backed FastForward Innovations (FFWD) on its Schoold deal at any moment as the 75 day exclusivity period with a potential strategic acquirer had reached an end. The anticlimactic news arrived on Friday (as covered in Tom’s Bearcast HERE) and I merely felt deflated but today I’ve woken up angry and wonder if FastForward has actually lied to me!
Cynical Bear has twice reported back on the great Jim Mellon Diabetic Boot spoof. This is a private company originally backed by Mellon with his own cash but then backed at ever higher valuations by PLCs controlled by Mellon, i.e with other folk's cash. But something happened before Christmas - surely the listed vehicles need to fess up? The spoof is not funny anymore, it is seriously related party unfunny;.
I almost spat out my cornflakes with laughter at the ridiculous announcement from Life Science Developments (LIFE) this morning as it entered suspension pending an RTO with The Diabetic Boot Company (“DBC”). Please allow me to explain.
Much to my wife’s amusement (and slight horror), I actually gave out a yelp of joy at just gone seven this morning while reading today’s company announcements, as I realised that Metal Tiger (MTR) had broken a long-standing world record. Let me explain…..
There is more horseshit today in an RNS from FastForward Innovations (FFWD), The money is running our fast. CEO Lorne Abony is in full ramping mode as he know he needs to get a placing away this fall or the game is up. The shares trade at a vast premium to NAV so what to do? Ramp again of course. All is explained in this bonus podcast.
I have a stack of dessert gooseberries. I know they should be in a fruit salad but I can't buy into that so want to put them into a crumble but with what? I seek answers from any gourmands or gourmets who are listening. Then I look at Alba (ALBA) in detail, its placing ahoy! I move through Northbridge Industrial (NBI), Gable (GAH) and the mystery of the dog that barked in the night, Gulf Keystone (GKP), Keller (KLR) and FastForward Innovations (FFWD).
In our recent coverage of FastForward Innovations (FFWD) both Cynical Bear and myself have pointed out that the maths in its ramptastic announcements to the mug punters who back this stock, simply do not add up. But there is a bigger problem...the company is running out of cash.
FastForward Innovations (FFWD) issued an after-hours RNS yesterday at 4.59pm announcing its next investment. Surely it wasn’t embarrassed by it? Let’s take a look.
In this , the 29th week of 2016, over-ramped bubble stock FastForward Innovations (FFWD) has just issued its 43rd RNS of the year. Pump, pump, pump...the dump is on its way. As a bonus the numbers in today's statement simply do not add up at all. It is pure shite but maybe the morons will buy it because another placing is on the way. Today's update concerns a Chinese Company called Yooya in which FastForward has invested.
How on earth did hapless Nomad Peel Hunt sign off on what Jim Mellon's FastForward Innovations (FFWD) terms a "strategic update" but is in fact nothing more than a shameless pre placing ramp.? My comments are in bold. FastForward's are not.
I’ve been looking forward to seeing the final results of FastForward Innovations (FFWD) which came out late yesterday due to a ridiculous comment that the CEO, Lorne Abony, made at the recent Master Investor Show.
Having been critical of the Lorne Abony show and FastForward innovation’s (FFWD) recent investments in Vemo and Schoold in my last piece HERE, I thought I’d take a closer look at one of the earlier investments, The Diabetic Foot Company (“DBC”), as, funnily enough, related parties raise their ugly head again there too.
Following on from a few bearish pieces from Tom on FastForward Innovations (FFWD) that you can see HERE, I have my own views on why what was the “Jim Mellon show” but is fast becoming the “Lorne Abony show” is a no-go investment for me.
Since March 3 in 25 working days, my old pal Jim Mellon's AIM casino listed FastForward Innovations (FFWD) has released 9 ramptastic good news RNS statements - one every three days. Since 31 March it has released 6 statements - that is to say almost one a day. It is almost as if Jim has been taking lessons from the master, Mr David Lenigas, on the art of the blizzard of ramptastic releases. Yet another placing with your tea vicar? It is also the nature of the releases that concerns me.
Featuring shares in Audioboom (BOOM), Finnaust Mining (FAM), Fastforward Innovations (FFWD), Kibo Mining (KIBO), Octagonal (OCT) and UK Oil & Gas (UKOG) with share price targets set for all six stocks.
